Skip to content

    INOVIO PHARMACEUTICALS (INO) stock price & financials

    View INO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance47.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $117.0K
    $65.3K
    $0
    $0
    $0
    -100.0%
    $0
    -100.0%
    $0
    Weakening
    Operating Profit
    -$27.35M
    -$20.37M
    -$25.05M
    -$23.08M
    -$21.21M
    +22.4%
    -$17.48M
    +14.2%
    -$21.95M
    +12.4%
    -$18.62M
    +19.3%
    Strengthening
    Net Profit
    -$25.17M
    -$19.38M
    -$19.69M
    -$23.52M
    -$45.50M
    -80.8%
    $3.76M
    -$19.68M
    +0.1%
    -$6.01M
    +74.4%
    Strengthening
    EPS
    $-0.89
    $-0.51
    $-0.61
    $-0.87
    +2.2%
    $-0.28
    +45.1%
    $-0.07
    +88.5%
    Strengthening
    Other Income
    Interest
    $0
    $0
    $0
    $0
    $0
    $0
    Depreciation
    Profit before Tax
    MarginsOPM
    -17410.8%
    -38337.0%
    Tax
    ReturnsROIC
    1.4%
    1.1%
    1.1%
    1.3%
    2.5%
    +80.8%
    -0.2%
    -119.4%
    1.1%
    -0.1%
    0.3%
    -74.4%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$23.69M$22.20M$250.73M$71.14M$46.33M$14.31M$65.81M$44.27M$31.53M
    Short-Term Investments
    Total Current Assets$87.81M$94.20M$471.17M$448.44M$315.24M$153.11M$97.83M$61.12M$39.91M
    Net PP&E$15.95M$26.56M$24.09M$29.02M$17.96M$14.45M$11.77M$9.07M$7.56M
    Goodwill$10.51M$10.51M$10.51M$10.51M$10.51M$0
    Intangibles$4.76M$3.69M$3.15M$2.63M$2.13M$0
    Total Assets$131.11M$143.95M$539.77M$495.94M$348.53M$170.95M$113.20M$74.31M$49.39M
    LiabilitiesTotal Current Liabilities$35.30M$31.99M$41.71M$65.74M$96.87M$42.57M$35.33M$43.67M$39.92M
    Short-Term Debt
    Long-Term Debt$0
    Long-Term Leases$20.41M$18.06M$15.46M$12.66M$11.03M$9.37M$6.55M$5.10M
    Total Liabilities$44.08M$138.55M$78.63M$96.27M$126.17M$53.60M$44.69M$50.21M$45.02M
    EquityCommon Stock & APIC$97.2K$101.4K$186.9K$217.4K$21.1K$22.8K$36.1K$69.0K$82.3K
    Retained Earnings-$620.43M-$739.79M-$906.20M-$1.21B-$1.49B-$1.62B-$1.73B-$1.82B-$1.84B
    Total Equity$86.94M$3.44M$461.14M$399.67M$222.36M$117.35M$68.50M$24.10M$4.37M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$73.55M-$97.85M-$177.98M-$215.71M-$216.22M-$124.37M-$104.08M-$88.63M-$80.58M
    Cash from Investing$42.42M-$9.04M-$58.80M-$175.34M$109.59M$87.36M$104.07M$14.04M$17.59M
    Cash from Financing$31.04M$105.40M$465.28M$211.50M$81.84M$5.00M$51.48M$53.05M$70.17M
    SummaryCapital Expenditure-$2.09M-$987.9K-$1.52M-$1.23M-$969.2K-$320.9K-$487.8K-$285.7K-$195.4K
    Free Cash Flow-$75.64M-$98.84M-$179.50M-$216.94M-$217.18M-$124.69M-$104.56M-$88.92M-$80.78M
    FCF Margin-248.1%-2403.7%-2422.0%-12223.6%-2116.3%-14986.2%-48019.1%-136074.5%

    Ratios